Novel selective MMP-13 inhibitors reduce collagen degradation in bovine articular and human osteoarthritis cartilage explants

No abstract is available for this paper.

• Publication year

  2010

• Venue

  Inflammation Research

• Publication date

  2010-05-01

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1007/s00011-009-0112-9PMID 19902332
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• A new class of potent matrix metalloproteinase 13 inhibitors for potential treatment of osteoarthritis: Evidence of histologic and clinical efficacy without musculoskeletal toxicity in rat models.

  2009influential reference
• Effect of the oral application of a highly selective MMP-13 inhibitor in three different animal models of rheumatoid arthritis

  2009cited by this paper
• Emerging roles of cysteine cathepsins in disease and their potential as drug targets.

  2007cited by this paper
• Role of cathepsin K in normal joints and in the development of arthritis.

  2007cited by this paper
• Discovery and Characterization of a Novel Inhibitor of Matrix Metalloprotease-13 That Reduces Cartilage Damage in Vivo without Joint Fibroplasia Side Effects*

  2007influential reference
• Blocking aggrecanase cleavage in the aggrecan interglobular domain abrogates cartilage erosion and promotes cartilage repair.

  2007cited by this paper
• Metalloproteinase and inhibitor expression profiling of resorbing cartilage reveals pro-collagenase activation as a critical step for collagenolysis

  2006cited by this paper
• Effects of doxycycline on progression of osteoarthritis: results of a randomized, placebo-controlled, double-blind trial.

  2005cited by this paper
• Matrix Metalloproteinase-13/Collagenase-3 Deletion Promotes Collagen Accumulation and Organization in Mouse Atherosclerotic Plaques

  2005cited by this paper
• Role of interleukin-1 and tumor necrosis factor alpha in matrix degradation of human osteoarthritic cartilage.

  2005cited by this paper
• Targeted inhibition of human collagenase-3 (MMP-13) expression inhibits squamous cell carcinoma growth in vivo

  2004cited by this paper
• Aggrecan Protects Cartilage Collagen from Proteolytic Cleavage*

  2003cited by this paper
• Metalloproteinases: their role in arthritis and potential as therapeutic targets

  2003cited by this paper
• Broad-spectrum matrix metalloproteinase inhibitor marimastat-induced musculoskeletal side effects in rats.

  2003cited by this paper
• Sites of collagenase cleavage and denaturation of type II collagen in aging and osteoarthritic articular cartilage and their relationship to the distribution of matrix metalloproteinase 1 and matrix metalloproteinase 13.

  2002cited by this paper
• The modulation of matrix metalloproteinase and ADAM gene expression in human chondrocytes by interleukin-1 and oncostatin M: a time-course study using real-time quantitative reverse transcription-polymerase chain reaction.

  2002cited by this paper
• Matrix metalloproteinases in arthritic disease

  2002cited by this paper
• Uncoupling of type II collagen synthesis and degradation predicts progression of joint damage in patients with knee osteoarthritis.

  2002cited by this paper
• Transcriptional regulation of collagenase (MMP-1, MMP-13) genes in arthritis: integration of complex signaling pathways for the recruitment of gene-specific transcription factors

  2001cited by this paper
• Metalloproteases and inhibitors in arthritic diseases.

  2001cited by this paper
• Postnatal expression in hyaline cartilage of constitutively active human collagenase-3 (MMP-13) induces osteoarthritis in mice.

  2001cited by this paper
• Comparison of the degradation of type II collagen and proteoglycan in nasal and articular cartilages induced by interleukin-1 and the selective inhibition of type II collagen cleavage by collagenase.

  2000cited by this paper
• An overview of collagenase-3 expression in malignant tumors and analysis of its potential value as a target in antitumor therapies.

  2000cited by this paper
• Selective enhancement of collagenase-mediated cleavage of resident type II collagen in cultured osteoarthritic cartilage and arrest with a synthetic inhibitor that spares collagenase 1 (matrix metalloproteinase 1).

  2000cited by this paper
• The Regulation of MMPs and TIMPs in Cartilage Turnover

  1999cited by this paper
• Inhibition of Articular Cartilage Degradation in Culture by a Novel Nonpeptidic Matrix Metalloproteinase Inhibitor

  1999cited by this paper
• The expression, refolding, and purification of the catalytic domain of human collagenase-3 (MMP-13).

  1998cited by this paper
• Enhanced cleavage of type II collagen by collagenases in osteoarthritic articular cartilage.

  1997influential reference
• Cloning, expression, and type II collagenolytic activity of matrix metalloproteinase-13 from human osteoarthritic cartilage.

  1996cited by this paper
• Biochemical Characterization of Human Collagenase-3 (*)

  1996cited by this paper

• Curcumin monoglucuronide protects cartilage from progressive degeneration by blocking MMP-13

  2025cites this paper
• Effects of adipose allograft matrix on viability of humeral head cartilage and rotator cuff tendon

  2025cites this paper
• Advances in the Study of Mechanisms by Which the Matrix Metalloproteinase Family Regulates the Development of Breast Cancer

  2024cites this paper
• On-demand release of a selective MMP-13 blocker from an enzyme-responsive injectable hydrogel protects cartilage from degenerative progression in osteoarthritis.

  2024cites this paper
• Screening of MMP-13 Inhibitors Using a GelMA-Alginate Interpenetrating Network Hydrogel-Based Model Mimicking Cytokine-Induced Key Features of Osteoarthritis In Vitro

  2024cites this paper
• Mechanism and pharmacotherapy of osteoarthritis – recent advances in the endocannabinoid system targeting”

  2023cites this paper
• Regulation of Peptidase Activity beyond the Active Site in Human Health and Disease

  2023cites this paper
• Pathogenesis and therapeutic implications of matrix metalloproteinases in intervertebral disc degeneration: A comprehensive review.

  2023cites this paper
• Latest insights in disease-modifying osteoarthritis drugs development

  2023cites this paper
• Chondrocyte-specific genomic editing enabled by hybrid exosomes for osteoarthritis treatment

  2022cites this paper
• Zn-containing Adhesives Facilitate Collagen Protection and Remineralization at the Resin-Dentin Interface: A Narrative Review

  2022cites this paper
• Long non-coding ribonucleic acid AFAP1-AS1 promotes chondrocyte proliferation via the miR-512-3p/matrix metallopeptidase 13 (MMP-13) axis

  2022cites this paper
• The collagenases: are they tractable targets for preventing cartilage destruction in osteoarthritis?

  2022cites this paper
• Development of a putative Zn2+-chelating but highly selective MMP-13 inhibitor.

  2022cites this paper
• New Directions in the Development of Pharmacotherapy for Osteoarthrosis Based on Modern Concepts of the Disease Pathogenesis (A Review)

  2022cites this paper
• lncRNA DLEU1 Modulates Proliferation, Inflammation, and Extracellular Matrix Degradation of Chondrocytes through Regulating miR-671-5p

  2022cites this paper
• Circ_0128846/miR-140-3p/JAK2 Network in Osteoarthritis Development

  2021cites this paper
• Changes of type II collagenase biomarkers on IL-1β-induced rat articular chondrocytes

  2021influential citation
• Polymeric zinc-doped nanoparticles for high performance in restorative dentistry.

  2021cites this paper
• CB2 agonism controls pain and subchondral bone degeneration induced by mono-iodoacetate: Implications GPCR functional bias and tolerance development.

  2021cites this paper
• New Trends in Pharmacological Treatments for Osteoarthritis

  2021cites this paper
• Sodium Monoiodoacetate Dose-Dependent Changes in Matrix Metalloproteinases and Inflammatory Components as Prognostic Factors for the Progression of Osteoarthritis

  2021cites this paper
• Matrix Metalloproteinase 13 Inhibitors for Modulation of Osteoclastogenesis: Enhancement of Solubility and Stability

  2020cites this paper
• Simple Pseudo-dipeptides with a P 2 (cid:1) Glutamate A NOVEL INHIBITOR FAMILY OF MATRIX METALLOPROTEASES AND OTHER

  2020cites this paper
• Inhibition of GPR17 with pranlukast protects against TNF-α-induced loss of type II collagen in ATDC5 cells.

  2020cites this paper
• PTH1-34 inhibited TNF-α expression and antagonized TNF-α-induced MMP13 expression in MIO mice.

  2020cites this paper
• Selective MMP-13 inhibitors: promising agents for the therapy of Osteoarthritis.

  2020cites this paper
• Pharmacotherapy for knee osteoarthritis: current and emerging therapies

  2020cites this paper
• Targeting Dysregulation of Metalloproteinase Activity in Osteoarthritis

  2020cites this paper
• A systematic computational analysis of human matrix metalloproteinase 13 (MMP-13) crystal structures and structure-based identification of prospective drug candidates as MMP-13 inhibitors repurposable for osteoarthritis

  2019cites this paper
• ACY-1215 exhibits anti-inflammatory and chondroprotective effects in human osteoarthritis chondrocytes via inhibition of STAT3 and NF-κB signaling pathways.

  2019cites this paper
• Design and Structural Evolution of Matrix Metalloproteinase Inhibitors.

  2019cites this paper
• Lunasin abrogates the expression of matrix metalloproteinases and reduction of type II collagen

  2019cites this paper
• The Adipokine Network in Rheumatic Joint Diseases

  2019cites this paper
• Profile of Matrix-Remodeling Proteinases in Osteoarthritis: Impact of Fibronectin

  2019cites this paper
• Chondrocyte and mesenchymal stem cell derived engineered cartilage exhibits differential sensitivity to pro‐inflammatory cytokines

  2018cites this paper
• A human osteoarthritis osteochondral organ culture model for cartilage tissue engineering.

  2018cites this paper
• In Vivo Imaging of MMP‐13 Activity Using a Specific Polymer‐FRET Peptide Conjugate Detects Early Osteoarthritis and Inhibitor Efficacy

  2018cites this paper
• Current status and future prospects for disease modification in osteoarthritis

  2018cites this paper
• Chapter 8 Specific Proteases for Osteoarthritis Diagnosis and Therapy

  2018cites this paper
• Investigational drugs for the treatment of osteoarthritis, an update on recent developments

  2018cites this paper
• Delivery of Agents Into Articular Cartilage With Electric Spark-Induced Sound Waves

  2018cites this paper
• High Throughput and Mechano-Active Platforms to Promote Cartilage Regeneration and Repair

  2017cites this paper
• Toll-like receptor 4 affects the expression of matrix metalloproteinase 13 in human chondrocytes

  2017cites this paper
• Recent Research Advances in Selective Matrix Metalloproteinase‐13 Inhibitors as Anti‐Osteoarthritis Agents

  2017cites this paper
• Clinical Implications of Compounds Designed to Inhibit ECM‐Modifying Metalloproteinases

  2017cites this paper
• Second Generation Triple-Helical Peptide Inhibitors of Matrix Metalloproteinases.

  2017cites this paper
• In vivo evaluation of Mg–6Zn and titanium alloys on collagen metabolism in the healing of intestinal anastomosis

  2017cites this paper
• Coptisine Prevented IL-β-Induced Expression of Inflammatory Mediators in Chondrocytes

  2016cites this paper
• Potential of Pseudoshikonin I Isolated from Lithospermi Radix as Inhibitors of MMPs in IL-1β-Induced SW1353 Cells

  2016cites this paper
• Functional characterization of selective exosite-binding inhibitors of matrix metalloproteinase-13 (MMP-13) – experimental validation in human breast and colon cancer

  2016cites this paper
• The Influence of Nuclear Magnetic Resonance Therapy ( NMRT ) and Interleukin IL 1-b Stimulation on Cal 78 Chondrosarcoma Cells and C 28 / I 2 Chondrocytes

  2016cites this paper
• 4. Metzincin Modulators

  2015cites this paper
• Specific Proteases for Osteoarthritis Diagnosis and Therapy

  2015cites this paper
• Radially oriented collagen scaffold with SDF-1 promotes osteochondral repair by facilitating cell homing.

  2015cites this paper
• New strategies for targeting matrix metalloproteinases

  2015cites this paper
• MicroRNA-411 inhibited matrix metalloproteinase 13 expression in human chondrocytes.

  2015cites this paper
• SAR Studies of Exosite-Binding Substrate-Selective Inhibitors of A Disintegrin And Metalloprotease 17 (ADAM17) and Application as Selective in Vitro Probes.

  2015cites this paper
• Lumican: A new inhibitor of matrix metalloproteinase‐14 activity

  2014cites this paper
• Identification and characterisation of microRNAs expressed in articular cartilage and osteoarthritis

  2014cites this paper
• Anti-inflammatory and chondroprotective activity of (+)-α-pinene: structural and enantiomeric selectivity.

  2014cites this paper
• Characterization of Selective Exosite-Binding Inhibitors of Matrix Metalloproteinase 13 That Prevent Articular Cartilage Degradation in Vitro

  2014cites this paper
• CIINE Reflects Collagenase-Specific CII Breakdown in Cartilage Explant and Whole Body of Canine

  2013cites this paper
• In vitro load-induced dentin collagen-stabilization against MMPs degradation.

  2013cites this paper
• This Provisional PDF corresponds to the article as it appeared upon acceptance. Copyedited and fully formatted PDF and full text (HTML) versions will be made available soon. Small molecule inhibitors of WNT/beta-catenin signaling block IL1beta/TNFalpha induced cartilage degradation

  2013cites this paper
• Profiling the Secretion of Soluble Mediators by End Stage Osteoarthritis Synovial Tissue Explants Reveals a Reduced Responsiveness to an Inflammatory Trigger

  2013cites this paper
• Small molecule inhibitors of WNT/β-catenin signaling block IL-1β- and TNFα-induced cartilage degradation

  2013cites this paper
• Effects of Supercritical Fluid Extract, Shikonin and Acetylshikonin from Lithospermum erythrorhizon on Chondrocytes and MIA-Induced Osteoarthritis in Rats

  2013cites this paper
• Healing Cartilage -Aspects on Regenerative Methods

  2013cites this paper
• Salvianolic acid B inhibits matrix metalloproteinases by NF-κB signaling in rabbit chondrocytes

  2012cites this paper
• Simple Pseudo-dipeptides with a P2′ Glutamate

  2012cites this paper
• The history of matrix metalloproteinases: milestones, myths, and misperceptions.

  2012cites this paper
• The History of Matrix Metalloproteinases ( MMPs ) : 1 Milestones , Myths , and ( Mis ) Perceptions

  2012cites this paper
• Proteases involved in cartilage matrix degradation in osteoarthritis.

  2012cites this paper
• Osteoarthritis: genetic factors, animal models, mechanisms, and therapies.

  2012cites this paper
• Prospects for treating osteoarthritis: enzyme–protein interactions regulating matrix metalloproteinase activity

  2012cites this paper
• Discovery and evaluation of a non-Zn chelating, selective matrix metalloproteinase 13 (MMP-13) inhibitor for potential intra-articular treatment of osteoarthritis.

  2012cites this paper
• Milestones, Myths, and (Mis)Perceptions

  2012cites this paper
• Destabilisation of the medial meniscus : imaging and mechanics of a murine surgical osteoarthritis model

  2012cites this paper
• myths, and misperceptions The history of matrix metalloproteinases: milestones,

  2012cites this paper
• Zinc-Inhibited MMP-Mediated Collagen Degradation after Different Dentine Demineralization Procedures

  2012cites this paper
• Simple pseudo dipeptides with a P 2 ’ glutamate: a novel inhibitor family of MMPs and other Metzincins*

  2012cites this paper
• Understanding the molecular basis for MMP-13 repression by IL-4

  2011cites this paper
• Effect of Phellodendron amurense in protecting human osteoarthritic cartilage and chondrocytes.

  2011cites this paper
• Bleaching agents increase metalloproteinases-mediated collagen degradation in dentin.

  2011cites this paper
• Effect of dentin etching and chlorhexidine application on metalloproteinase-mediated collagen degradation.

  2011cites this paper
• Selective Inhibition of Matrix Metalloproteinase-13 Increases Collagen Content of Established Mouse Atherosclerosis

  2011cites this paper
• Identification of novel, exosite-binding matrix metalloproteinase-13 inhibitor scaffolds.

  2011cites this paper
• New opportunities in drug design of metalloproteinase inhibitors: combination between structure–function experimental approaches and systems biology

  2011cites this paper
• Zinc reduces collagen degradation in demineralized human dentin explants.

  2011cites this paper
• Patent Evaluation Metalloproteinase binding proteins : WO 2009097397 Yoshifumi Itoh

  2010cites this paper
• Scarless wound healing.

  2010cites this paper
• Cheminformatics-Based Drug Design Approach for Identification of Inhibitors Targeting the Characteristic Residues of MMP-13 Hemopexin Domain

  2010cites this paper
• Effects of adenovirus-mediated bFGF, IL-1Ra and IGF-1 gene transfer on human osteoarthritic chondrocytes and osteoarthritis in rabbits

  2010cites this paper
• Treatment of osteoarthritis in hypertensive patients

  2010cites this paper
• Metalloproteinase binding proteins: WO2009097397

  2010cites this paper